Biosimilars Market Share

Europe Market Forecast

The Europe biosimilars market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed majorly to the presence of a strong healthcare network in the region, and the growing number of hospitals and diseases. As per the reported data, nearly 10 percent of the total population in the United States were suffering from diabetes in the year 2021. Moreover, the rising awareness of biosimilars amongst the healthcare service providers, along with the surge in prescribing biosimilars, is further anticipated to drive the growth of the market in the region. Furthermore, the volume of biosimilar prescribing has generated high savings from biosimilar competition, and it is projected to drive the market’s growth in the region.